CA1043259A - Medicament preparations and vehicles therefor - Google Patents

Medicament preparations and vehicles therefor

Info

Publication number
CA1043259A
CA1043259A CA186,345A CA186345A CA1043259A CA 1043259 A CA1043259 A CA 1043259A CA 186345 A CA186345 A CA 186345A CA 1043259 A CA1043259 A CA 1043259A
Authority
CA
Canada
Prior art keywords
composition
medicament
glycol
dialkylated
alpha
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
CA186,345A
Other languages
English (en)
French (fr)
Other versions
CA186345S (en
Inventor
Geoffrey F. Thompson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Syntex USA LLC
Original Assignee
Syntex USA LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US00313431A external-priority patent/US3833725A/en
Application filed by Syntex USA LLC filed Critical Syntex USA LLC
Application granted granted Critical
Publication of CA1043259A publication Critical patent/CA1043259A/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
CA186,345A 1972-12-08 1973-11-21 Medicament preparations and vehicles therefor Expired CA1043259A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US00313431A US3833725A (en) 1972-12-08 1972-12-08 Dialkylated glycol compositions and medicament preparations containing same
US41396573A 1973-11-08 1973-11-08

Publications (1)

Publication Number Publication Date
CA1043259A true CA1043259A (en) 1978-11-28

Family

ID=26978866

Family Applications (1)

Application Number Title Priority Date Filing Date
CA186,345A Expired CA1043259A (en) 1972-12-08 1973-11-21 Medicament preparations and vehicles therefor

Country Status (6)

Country Link
JP (1) JPS5726244B2 (ref)
CA (1) CA1043259A (ref)
DE (1) DE2358644C3 (ref)
ES (1) ES421299A1 (ref)
FR (1) FR2209544B1 (ref)
GB (1) GB1454109A (ref)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5391110A (en) * 1977-01-20 1978-08-10 Yamanouchi Pharmaceut Co Ltd Novel drug composition for rectal infusion
US4115563A (en) * 1977-03-14 1978-09-19 Sterling Drug Inc. Pharmaceutical steroid formulation
US4310543A (en) * 1980-10-09 1982-01-12 Hoffmann-La Roche Inc. Prostaglandin compositions
AU546872B2 (en) * 1982-06-16 1985-09-26 Unilever Plc Skin treatment compositions containing a fatty acid or ester
GB8718886D0 (en) * 1987-08-10 1987-09-16 Ici America Inc Composition
US9327060B2 (en) * 2009-07-09 2016-05-03 CARDINAL HEALTH SWITZERLAND 515 GmbH Rapamycin reservoir eluting stent

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1296515A (fr) * 1958-12-05 1962-06-22 Boehringer & Soehne Gmbh Procédé de fabrication de solutions de chloramphénicol dans des liquides aqueux
US3308217A (en) * 1965-02-09 1967-03-07 Lowy Lawrence Method of granulating materials for subsequent forming into tablets

Also Published As

Publication number Publication date
JPS5052220A (ref) 1975-05-09
DE2358644C3 (de) 1979-11-15
AU6319173A (en) 1975-06-05
DE2358644B2 (de) 1979-04-05
GB1454109A (en) 1976-10-27
DE2358644A1 (de) 1974-07-04
ES421299A1 (es) 1977-05-16
FR2209544A1 (ref) 1974-07-05
JPS5726244B2 (ref) 1982-06-03
FR2209544B1 (ref) 1978-03-24

Similar Documents

Publication Publication Date Title
USRE28819E (en) Dialkylated glycol compositions and medicament preparations containing same
US4011313A (en) Medicament preparations
EP0063367B1 (en) Acetal stabilized prostaglandin compositions
CA1176567A (en) Pharmaceutical preparation
CA1203172A (en) Propylene glycol diester solutions of pge-type compounds
US4889845A (en) Vehicle for topical application of pharmaceuticals
EP1028708B1 (en) Topical compositions for prostaglandin e1 delivery
JP4783794B2 (ja) 軟ゼラチンカプセル製剤
AU2003300113B2 (en) Topical stabilized prostaglandin E compound dosage forms
CA1043259A (en) Medicament preparations and vehicles therefor
EP1310256B1 (en) Use of prostaglandin A or its derivatives for the treatment of psoriasis
EP0345951B1 (en) Tracheobronchodilator
US3833725A (en) Dialkylated glycol compositions and medicament preparations containing same
US3826823A (en) Stabilized prostaglandin preparations
EP1855648A2 (en) Topical stabilized prostaglandin e compound dosage forms
EP3506947A1 (en) Pharmaceutical formulations of regadenoson
Šimek et al. Effect of glucose administered in vivo or in vitro on the respiratory quotient of rat liver tissue after partial hepatectomy
US2752284A (en) Spermicidal composition
EP0038013A2 (en) Injectable oxytetracycline compositions
JPS6253933A (ja) 外皮投与用組成物
US12324790B1 (en) Preparation method and application of micelle preparation containing thymol and derivative thereof
US5362751A (en) Tracheobronchodilator using 16-substituted PGEs
KR890002239B1 (ko) 인도메타신 연고제의 제조방법
JPS6463552A (en) 4-biphenylylacetic acid ester-cyclodextrin inclusion compound
CN116803375A (zh) 一种烯丙孕素内服溶液及其制备方法